Visugromab in Cachexia International Trial

Clinical trial NCT07112196 · RECRUITING

Trial details

NCT number: NCT07112196
Sponsor: CatalYm GmbH
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Cancer-associated Cachexia

Start date: 2026-04-16
Primary completion: 2029-12-01
Enrollment: 518

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.